Proposed USPTO Fee Changes Could Impact PGR And IPR Filing Strategies Used By Biosimilars

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
The USPTO has proposed several fee changes for implementation in 2025. If implemented, these changes will increase filing fees for Inter Partes Reviews (IPRs)
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

The USPTO has proposed several fee changes for implementation in 2025. If implemented, these changes will increase filing fees for Inter Partes Reviews (IPRs) and Post Grant Reviews (PGRs) by 25% "to improve cost recovery." Additionally, the PTO is proposing to allow IPR and PGR petitions to exceed the current word limits (14,000 and 18,700, respectively) via a new fee structure. The goal behind this new approach is to reduce the number of parallel petitions being filed by increasing the allowed word counts. The proposal suggests 50% and 100% increases in word counts for payment of additional fees equal to 50% and 100% of the initial filing fees. Fees incurred for additional words post-institution would be higher than those levied pre-institution.

For example, pre-institution:

  1. IPR requests for up to 20 claims and 14,000 words would be $23,750. Up to 7,000 additional words would cost an additional $11,875 and up to 14,000 additional words would incur an additional fee of $23,750.
  2. PGR requests for up to 20 claims and 18,700 words would be $25,000. Up to 9,350 additional words would cost an additional $12,500 and up to 18,700 additional words would incur an additional fee of $25,000.

The USPTO is also proposing a new fee of $440 for any party requesting review of a PTAB decision by the director, post-Arthrex. This fee is set to match that of the Petitions to the Chief Administrative Judge Fee.

Anyone wishing to submit written comments on the proposed changes should visit the Federal eRulemaking Portal at www.regulations.gov. To submit comments via the portal, commenters should enter docket number PTO-P-2023-0017 on the homepage.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Proposed USPTO Fee Changes Could Impact PGR And IPR Filing Strategies Used By Biosimilars

United States Intellectual Property

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More